In HCC, Tan S et al (Tan et al., 2022) conformed that hsa-miR-9-5p-mediated Tspan9 downregulation was related to tumor immune infiltration and poor prognosis. This evidence concerns the gene TSPAN9 and hepatocellular carcinoma.